Testing effectiveness (Phase 2)Study completedNCT00031655
What this trial is testing
Reduced Intensity Donor Stem Cell Transplant in Treating Patients With High Risk Acute Lymphocytic Leukemia in Complete Remission
Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionChildhood Acute Lymphoblastic Leukemia in RemissionRecurrent Adult Acute Lymphoblastic Leukemia+1 more
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 30